NCT06749548

Brief Summary

Multi-detector computed tomography angiography (MDCTA) provides high-resolution images of the heart and its vasculature, allowing for accurate anatomical assessment, detection of complex cardiac morphology,

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
122

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 27, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2025

Completed
Last Updated

December 27, 2024

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

December 19, 2024

Last Update Submit

December 19, 2024

Conditions

Congenital Heart Disease

Outcome Measures

Primary Outcomes (1)

  • Computed Tomgraphy Angiogrpahy

    All patients will undergo MDCT using a 128-slice scanner. A contrast agent will be administered to visualize the heart's vascular structures. Detailed images of the heart's chambers, major blood vessels, and defects will be acquired

    12 Months

Interventions

Group 1RADIATION

the study is to emphasize the role of Computed Tomography Angiography (MDCTA) and Transthoracic Echocardiography (Echo) in the diagnosis of congenital cyanotic heart diseases.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

the Aim is to compare the Multidetector CT and TE in the Diagnosis of Congenital Cyanotic Heart Diseases

You may qualify if:

  • age above 18 and less than 65.
  • having Congenital Cyanotic Heart Diseases

You may not qualify if:

  • heart surgery
  • other heart issues
  • not consented

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Timergara Teaching Hospital, Timergara District Dir Lower

Peshawar, Khyber Pakhtunkhwa, Pakistan

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 19, 2024

First Posted

December 27, 2024

Study Start

March 1, 2024

Primary Completion

September 1, 2024

Study Completion

March 2, 2025

Last Updated

December 27, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations

PA(1)